Trials / Conditions / XIAP Deficiency
XIAP Deficiency
3 registered clinical trials studyying XIAP Deficiency — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Quercetin in Patients With XIAP (X-linked Inhibitor of Apoptosis) Deficiency NCT07433621 | Children's Hospital Medical Center, Cincinnati | Phase 1 |
| Completed | Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency As Open Label Extension NCT03512314 | AB2 Bio Ltd. | Phase 3 |
| Completed | Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency NCT03113760 | AB2 Bio Ltd. | Phase 3 |